Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus

To evaluate the reasons for changing to monotherapy with protease inhibitors, together with the proportion and reasons for the interruption to treatment, in patients who have been treated at some point with cobicistat-boosted darunavir (DRV/c). Outpatients in a tertiary hospital. Observational retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Solana-Altabella, Antonio, Monte-Boquet, Emilio, Montero, Marta, Pérez-Huertas, Pablo, Cuéllar-Monreal, Maria Jesús, Salavert, Miguel, Poveda-Andrés, José Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
4850
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750541/
https://www.ncbi.nlm.nih.gov/pubmed/36626459
http://dx.doi.org/10.1097/MD.0000000000032208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750541/
https://www.ncbi.nlm.nih.gov/pubmed/36626459
http://dx.doi.org/10.1097/MD.0000000000032208

Ejemplares similares